Molecular Genetics & Genomic Medicine (Feb 2023)

Nance–Horan syndrome pedigree due to a novel microdeletion and skewed X chromosome inactivation

  • Yazhou Huang,
  • Linya Ma,
  • Zhaoxia Zhang,
  • Shujuan Nie,
  • Yuan Zhou,
  • Jibo Zhang,
  • Chao Wang,
  • Xingxin Fang,
  • Yingting Quan,
  • Ting He,
  • Anhui Liu,
  • Dan Peng

DOI
https://doi.org/10.1002/mgg3.2100
Journal volume & issue
Vol. 11, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Background Nance–Horan syndrome (NHS) is a rare and often overlooked X‐linked dominant disorder characterized by dense congenital cataracts, dental abnormalities, and mental retardation. The majority of NHS variations include frameshift mutations, nonsense mutations, microdeletions, and insertions. Methods Copy number variation sequencing was performed to determine the microdeletion. The expression of NHS was detected by RT‐PCR. Four family members were tested for X chromosome inactivation. Results In this study, all members were examined for systemic examinations and genetic testing of four members and two affected subjects are observed. We identified a heterozygous microdeletion of −0.52 Mb at Xp22.13 in a female proband presenting NHS phenotypically. The microdeletion contains the REPS2 and NHS genes and was inherited from a phenotypically normal mother. Of interest, the expression NHS of proband was reduced and the skewed X chromosome inactivation rate reached more than 85% compared with her mother and the control. It was concluded that the haploinsufficiency of the NHS gene may account for the majority of clinical symptoms in the affected subjects. The variability among female carriers presumably results from nonrandom X chromosome inactivation. Conclusion Our findings broaden the spectrum of NHS mutations and provide molecular insight into NHS clinical prenatal genetic diagnosis.

Keywords